Apr. 18, 2026
Canyon Lake community gathers for Michelle's Place cancer event
Luminarias, Wall of Hope honor those affected by cancer at annual 'Hope Lights the Night' gathering
Apr. 18, 2026
Pliant Therapeutics Presents Positive Phase 1 Data for PLN-101095 in Solid Tumors
Combination therapy shows deepening tumor responses and increased time on treatment in difficult-to-treat cancers
Apr. 18, 2026
Johns Hopkins Kimmel Cancer Center Researchers Honored at AACR Annual Meeting
Experts from the cancer center present new findings and receive prestigious awards at the leading cancer research conference.
Apr. 17, 2026
ORIC Pharmaceuticals Presents Prostate Cancer Drug Data at AACR
Preclinical findings support potential of rinzimetostat in prostate cancer and emerging resistance settings
Apr. 17, 2026
City of Hope Scientists to Share New Findings on Cancer Risk, Immune Resistance and AI-Driven Discovery at AACR 2026
Minisymposia data will explore why cancers develop earlier, how tumors evade treatment and how AI is reshaping cancer research and immunotherapy.
Apr. 17, 2026
Soley Therapeutics Presents Promising Preclinical Data for Cancer Drug Candidate
STX-6398 shows selective anti-tumor activity and biomarker-linked efficacy in preclinical studies.
Apr. 17, 2026
Pheast Therapeutics Reports Early Clinical Promise for PHST001 at AACR 2026
Initial Phase 1a data show favorable safety profile and signs of anti-tumor activity for novel macrophage checkpoint inhibitor
Apr. 17, 2026
Ludwig Researchers to Present at AACR 2026 Conference
Experts from Ludwig Cancer Research will share their discoveries at the annual oncology event.
Apr. 17, 2026
Boundless Bio Presents Preclinical Breast Cancer Data from Kinesin Degrader Program
Findings support ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader.
Apr. 17, 2026
Annual Swing Against Cancer Raises Funds for Research and Support
The 11th annual event in Palm Springs aims to make strides in the fight against cancer.
Apr. 17, 2026
Pyxis Oncology Presents Promising Preclinical Data on MICVO for HNSCC
Combination with anti-PD-1 shows synergistic anti-tumor activity in immunotherapy-refractory model
Apr. 17, 2026
ORIC Pharmaceuticals Presents Prostate Cancer Potential of Rinzimetostat at AACR
Preclinical data highlights rinzimetostat's ability to overcome resistance and improve response to androgen receptor therapies.
Apr. 17, 2026
MiNK Therapeutics Reports Promising Phase II Data on Immune Reprogramming and Survival in PD-1 Refractory Gastroesophageal Cancer
Combination therapy with agenT-797, botensilimab, and balstilimab shows high disease control rate and long-term survival in subset of patients
Apr. 17, 2026
Accent Therapeutics Presents Promising Data on Novel KIF18A Inhibitor ATX-295 at AACR
Preclinical results demonstrate robust anti-cancer activity of ATX-295 in chromosomally unstable tumor models
Apr. 17, 2026
Moderna to Present Phase 1/2 Data on Cancer Therapy mRNA-4359 at AACR
The investigational therapy showed promising results in combination with pembrolizumab for locally advanced or metastatic melanoma.
Apr. 17, 2026
Boston Musician Undergoes Complex Brain Surgery, Returns to Stage in 9 Weeks
Renowned neurosurgeon removes rare petroclival meningioma, highlighting importance of seeking expert care
Apr. 17, 2026
Xilio Therapeutics Unveils Promising Preclinical Data for Masked T Cell Engager XTX601
New findings at AACR Annual Meeting highlight potential for wide therapeutic index and favorable tolerability profile
Apr. 17, 2026
GigaGen presents positive phase 1 data on non-blocking anti-CTLA-4 drug candidate GIGA-564
GIGA-564 demonstrated a favorable safety profile while exhibiting early signals of anti-tumor activity in solid tumors
Apr. 17, 2026
AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
Novel assay developed on Akoya PhenoImager HT platform with Opal chemistry becomes first to predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.
Apr. 17, 2026
Sleep Loss Linked to Gut Bacteria Changes, Worsening Colon Cancer
UF Health researchers find sleep deprivation alters microbiome, weakens immune system and chemotherapy response
